BACKGROUND: The availability of novel direct-acting antivirals(DAAs) represents a new era of curative hepatitis C virus(HCV) treatment, with over 95% of patient
BACKGROUND: With the expansion of surgical criteria, the comparative efficacy between surgical resection(SR) and liver transplantation(LT) for hepatocellular ca
BACKGROUND: Transcatheter arterial chemoembolization(TACE) and TACE in combination with sorafenib(TACEsorafenib) have shown a significant survival benefit for t